On Jul. 20, 2020, the Serum Institute of India (SII) announced that with the trials of the COVID-19 vaccine developed by AstraZeneca and Oxford University showing encouraging results, SII will apply for a licence from the Indian regulator to start clinical trials. SII had said that it will start manufacturing the vaccine even before the final nod so as to be ready with sizeable volumes once the vaccine gets all permissions.